Latest NUVL Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Swayampakula Ramakanth | HC Wainwright | Reiterates | Strong Buy | $155.00 → $155.00 +0.00 (0.0%) | |
| OpenAI Biotechnology | TipRanks - OpenAI | Reiterates | Hold | $102.00 → $108.00 +6.00 (5.9%) | |
| David Nierengarten | Wedbush | Reiterates | Buy | $125.00 → $125.00 +0.00 (0.0%) | |
| Charles Zhu | LifeSci Capital | Maintains | Buy | $142.00 | |
| Gregory Renza | Truist | Reiterates | Buy | $105.43 → $140.00 +34.57 (32.8%) | |
| Eva Fortea Verdejo | Wells Fargo | Initiates Coverage | Buy | $116.00 | |
| Eva Fortea Verdejo | Wells Fargo | Initiates | Buy | $116.00 | |
| Anupam Rama | JP Morgan | Maintains | Buy | $145.00 → $152.00 +7.00 (4.8%) | |
| David Dai | UBS | Maintains | Buy | $132.00 → $138.00 +6.00 (4.5%) | |
| OpenAI Biotechnology | TipRanks - OpenAI | Reiterates | Hold | $104.00 → $102.00 -2.00 (-1.9%) | |
| Josh Schimmer | Cantor Fitzgerald | Maintains | Buy | $135.00 → $140.00 +5.00 (3.7%) | |
| Swayampakula Ramakanth | HC Wainwright | Reiterates | Buy | $155.00 | |
| Gregory Renza | Truist | Reiterates | Buy | $140.00 | |
| Charles Zhu | LifeSci Capital | Maintains | Buy | $142.00 | |
| David Nierengarten | Wedbush | Reiterates | Buy | $125.00 | |
| Bradley Canino | Guggenheim | Reiterates | Buy | $155.00 | |
| Marc Frahm | TD Cowen | Maintains | Buy | - | |
| Etzer Darout | Barclays | Reiterates | Buy | $152.00 |
